Coenzyme Q and cardiovascular health -
A simple blood test is available to measure CoQ10 levels. A shortage of this antioxidant may lead to oxidative stress, which increases the risk for a range of disorders, including CVD. Cholesterol-lowering statins may also reduce blood levels of CoQ Recent studies suggest that CoQ10, either alone or combined with other therapies, may be beneficial for the following conditions.
What is Coenzyme Q10? What are the different forms of CoQ10? How does CoQ10 affect heart health? Cardiovascular disease CVD. Recent studies show that CoQ10 supplements can significantly increase HDL-C and ApoA1 levels, even in people taking statins, and may help reduce risk for CVD.
CoQ10 supplementation also lowers levels of inflammatory biomarkers shown to be risk factors for CVD, such as high-sensitivity C-reactive protein. Finally, low CoQ10 levels have been associated with greater tissue damage to the heart during a heart attack and the brain during stroke.
Statin-related muscle symptoms. Although statin therapy can significantly reduce heart attack and stroke risk , up to 25 percent of patients quit treatment within six months due to side effects, such as muscle aches and weakness. Improvement in intestinal coenzyme q10 absorption by food intake.
Yakugaku Zasshi. Ostrowski RP. Effect of coenzyme Q 10 on biochemical and morphological changes in experimental ischemia in the rat brain.
Brain Res Bull. Palan PR, Connell K, Ramirez E, Inegbenijie C, Gavara RY, Ouseph JA, Mikhail MS. Effects of menopause and hormone replacement therapy on serum levels of coenzyme Q10 and other lipid-soluble antioxidants.
Quinzii CM, Dimauro S, Hirano M. Human coenzyme q 10 deficiency. Neurochem Res. Raitakari OT, McCredie RJ, Witting P, Griffiths KA, Letter J, Sullivan D, Stocker R, Celermajer DS. Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults.
Free Radic Biol Med. Rakel D. Rakel: Integrative Medicine. Philadelphia, PA: Elsevier Saunders; Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Conenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.
J Hum Hypertens. Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Salles JE, Moises VA, Almeida DR, Chacra AR, Moises RS. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q Diabetes Res Clin Pract.
Sander S, Coleman CI, Patel AA, Kluger J, White CM. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail. Shults CW, Haas R. Clinical trials of coenzyme Q10 in neurological disorders.
Shults CW. Therapeutic role of coenzyme Q 10 in Parkinson's disease. Pharmacol Ther. Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and heart failure. Nutr Rev.
Spigset O. Reduced effect of warfarin caused by ubidecarenone. Torkos S. Drug-nutrient interactions: A focus on cholesterol-lowering agents.
Int J Integrative Med. Watson PS, Scalia GM, Galbraith A, et al. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.
J Am Coll Cardiol. Weant KA, Smith KM. The role of coenzyme Q10 in heart failure. Ann Pharmacother. Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. Share Facebook Twitter Linkedin Email Home Health Library.
Coenzyme Q10 CoQ10; Ubiquinone. Uses Some studies suggest that coenzyme Q10 supplements, either by themselves or in with other drug therapies, may help prevent or treat the following conditions: After Heart Attack One clinical study found that people who took daily CoQ10 supplements within 3 days of a heart attack were less likely to have subsequent heart attacks and chest pain.
Heart failure HF There is evidence that CoQ10 may help treat heart failure when combined with conventional medications. High blood pressure Several clinical studies involving small numbers of people suggest that CoQ10 may lower blood pressure.
High cholesterol People with high cholesterol tend to have lower levels of CoQ10, so CoQ10 has been proposed as a treatment for high cholesterol, but scientific studies are lacking. Diabetes CoQ10 supplements may improve heart health and blood sugar and help manage high blood pressure in people with diabetes.
Heart damage caused by chemotherapy Several clinical studies suggest that CoQ10 may help prevent heart damage caused by certain chemotherapy drugs, adriamycin, or other athracycline medications. Heart surgery Clinical research indicates that introducing CoQ10 prior to heart surgery, including bypass surgery and heart transplantation, can reduce damage caused by free radicals, strengthen heart function, and lower the incidence of irregular heart beat arrhythmias during the recovery phase.
Gum Periodontal disease Gum disease is a common problem that causes swelling, bleeding, pain, and redness of the gums.
Other Preliminary clinical studies also suggest that CoQ10 may: Improve immune function in people with HIV or AIDS Increase sperm motility, improving male fertility Be used as part of the treatment for Parkinson disease Improve exercise ability in people with angina Help prevent migraines Scientific studies are needed to see whether CoQ10 can be safely and effectively used for these health problems and needs.
Dietary Sources Primary dietary sources of CoQ10 include oily fish such as salmon and tuna , organ meats such as liver , and whole grains. Available Forms CoQ10 is available as a supplement in several forms, including soft gel capsules, oral spray, hard shell capsules, and tablets.
How to Take It Pediatric DO NOT give CoQ10 to a child under 18 except under the supervision of a health care provider. Adult For adults 19 years and older: The recommended dose for CoQ10 supplementation is 30 to mg daily.
Orlando P, Sabbatinelli J, Silvestri S, et al. Ubiquinol supplementation in elderly patients undergoing aortic valve replacement: biochemical and clinical aspects. Aging Albany NY ;— Kawashima C, Matsuzawa Y, Konishi M, et al.
Ubiquinol improves endothelial function in patients with heart failure with reduced ejection fraction: a single-center, randomized double-blind placebo-controlled crossover pilot study. Am J Cardiovasc Drugs. Holmberg MJ, Andersen LW, Moskowitz A, et al. Ubiquinol reduced coenzyme Q10 as a metabolic resuscitator in post-cardiac arrest: a randomized, double-blind, placebo-controlled trial.
Samuel TY, Hasin T, Gotsman I, et al. Coenzyme Q10 in the treatment of heart failure with preserved ejection fraction: a prospective, randomized, double-blind, placebo-controlled trial. Drugs R D. Am J Cardiol. Showing that higher concentrations of CoQH2 are needed to reach any effect.
Caso G, Kelly P, McNurlan MA, et al. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study. Drug Des Devel Ther.
Skarlovnik A, Janić M, Lunder M, et al. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit ;— Ernster L, Forsmark-Andrée P. Ubiquinol: an endogenous antioxidant in aerobic organisms.
Niki E. Mechanisms and dynamics of antioxidant action of ubiquinol. Wang TY, Liu M, Portincasa P, et al. New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Invest. Download references. Institute of Pharmaceutical Sciences, University of Graz, Beethovenstraße 8, , Graz, Austria.
Apomedica Pharmazeutische Produkte GmbH, Roseggerkai 3, , Graz, Austria. You can also search for this author in PubMed Google Scholar. All authors had full access to the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and study design as well as manuscript writing was performed by JPF. SG did the data preparation and conducted the table. All authors read and approved the manuscript.
Correspondence to Johannes-Paul Fladerer. JPF reported receiving personal fees from Apomedica Pharmazeutische Produkte GmbH as part-time employee.
The authors declare no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Reprints and permissions. Fladerer, JP. Comparison of Coenzyme Q10 Ubiquinone and Reduced Coenzyme Q10 Ubiquinol as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality. Curr Cardiol Rep 25 , — Download citation. Accepted : 31 October Published : 16 November Issue Date : December Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Download PDF. Abstract Purpose of Review According to the World Health Organization WHO , cardiovascular disease is the leading cause of death worldwide.
Summary Based on the existing literature, the authors recommend CoQ10 instead of CoQH2 to treat and prevent cardiovascular disease in patients with heart failure. Coenzyme Q10 — A new player in the treatment of heart failure? Article 17 July Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?
Article 23 June Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: a Systematic Review Article 16 May Use our pre-submission checklist Avoid common mistakes on your manuscript. Introduction According to the World Health Organization WHO , cardiovascular disease CVD is the leading cause of death worldwide [ 1 ].
Full size image. Objectives Our goal is to determine differences in medical application of CoQ10 and CoQH2 supplementation and evaluate the efficacy of CoQ10 and CoQH2 supplementation to prevent cardiovascular diseases.
Types of Outcome Measures To determine differences in medical application of CoQ10 and CoQH2 supplementation, we assigned the studies to the following applications: antioxidative activity, bronchial diseases, cancer, cardiovascular diseases, eye diseases, hepatic diseases, Huntington, infections, infertility, inflammation, mental health, metabolic syndrome, migraine, mitochondrial dysfunction, pain, Parkinson, physical health, polycystic ovary syndrome, pregnancy, presbycusis, statin associated pain, others.
Data Collection and Analysis Two authors independently selected trials for inclusion, abstracted data and assessed the risk of bias. Results We identified randomised controlled trials for ubiquinone and 35 for ubiquinol, which were sorted by medical application.
Study flow diagram. Table 1 Effects of CoQ10 and CoQH2 on cardiovascular diseases. Empty cells are used if information is missing Full size table.
Discussion Even 30 years ago, studies recorded the beneficial effect of CoQ10 supplementation alone or in combination with selenium to improve EF [ 16 ], reduce time of hospitalisation [ 17 ] and reduce cardiovascular mortality in patients with heart failure [ 30 ].
Conclusion As detailed above, our findings go along with the literature and the biochemical description of CoQ10 and CoQH2, recording cardiovascular benefits for CoQ10 and antioxidative and anti-inflammatory properties for CoQH2 [ 7 , 8 ]. Data Availability Data and additional informations are available on request.
Google Scholar Global Health Metrics. Article Google Scholar Savarese G, Becher PM, Lund LH, et al. Article CAS PubMed Google Scholar Sue-Ling CB, Abel WM, Sue-Ling K.
Article PubMed Google Scholar Linnane AW, Kios M, Vitetta L. Article CAS PubMed Google Scholar Mantle D, Dybring A. Article CAS PubMed Google Scholar Littarru GP, Tiano L. Article CAS PubMed Google Scholar Yubero-Serrano EM, Gonzalez-Guardia L, Rangel-Zuñiga O, et al.
PubMed Google Scholar Judy WV. PubMed Google Scholar López-Lluch G, Del Pozo-Cruz J, Sánchez-Cuesta A, et al. Article CAS PubMed Google Scholar Raizner AE, Quiñones MA. Article CAS PubMed Google Scholar Gutierrez-Mariscal FM, La Cruz-Ares S de, Torres-Peña JD et al.
Article CAS PubMed Google Scholar Morisco C, Trimarco B, Condorelli M. Article CAS PubMed Google Scholar Chello M, Mastroroberto P, Romano R, et al.
Article CAS PubMed Google Scholar Morisco C, Nappi A, Argenziano L, et al. Article PubMed Google Scholar Singh RB, Wander GS, Rastogi A, et al. Article CAS PubMed Google Scholar Berman M, Erman A, Ben-Gal T, et al.
Article PubMed Google Scholar Chew GT, Watts GF, Davis TME, et al. Article CAS PubMed PubMed Central Google Scholar Makhija N, Sendasgupta C, Kiran U, et al. Article CAS PubMed Google Scholar Kuimov AD, Murzina TA. Article PubMed Google Scholar Aslanabadi N, Safaie N, Asgharzadeh Y, et al.
Article CAS PubMed Google Scholar Mortensen AL, Rosenfeldt F, Filipiak KJ. Article PubMed PubMed Central Google Scholar Sobirin MA, Herry Y, Sofia SN, et al. Article CAS PubMed Google Scholar Khan A, Johnson DK, Carlson S, et al. Article PubMed Google Scholar Kuklinski B, Weissenbacher E, Fähnrich A.
Article PubMed Google Scholar Alehagen U, Aaseth J, Johansson P. Article CAS PubMed PubMed Central Google Scholar Alehagen U, Lindahl TL, Aaseth J, et al. Article CAS PubMed PubMed Central Google Scholar Alehagen U, Alexander J, Aaseth J.
Article CAS PubMed PubMed Central Google Scholar Alehagen U, Aaseth J, Lindahl TL, et al.
According cardiovascularr the World Health Organization WHOcardiovascular disease is Coenzyme Q and cardiovascular health leading cause of Coenzyme Q and cardiovascular health worldwide. Heart Conzyme has been defined as Cornzyme global pandemic leading Coemzyme millions Liver Health Measures deaths. Recent research clearly approved the beneficial effect of Coenzyme Q10 Nutritional tips for weightlifters in cardivoascular and prevention of cardiovascular disease in patients with heart failure in clinical trials but did not distinguish between the oxidised form CoQ10 and reduced form CoQH2 of Coenzyme Q The aim of this study is to determine differences in medical application of CoQ10 and CoQH2 supplementation and evaluate the efficacy of CoQ10 and CoQH2 supplementation to prevent cardiovascular disease in patients with heart failure. Our findings go along with the biochemical description of CoQ10 and CoQH2, recording cardiovascular benefits for CoQ10 and antioxidative and anti-inflammatory properties for CoQH2. Jump to navigation. Preventing diabetes during pregnancy failure is a term used to describe cardiovascuoar state that develops when the Coenzyne cannot maintain adequate cardiac output, xardiovascular can do Coenzyme Q and cardiovascular health only at the expense of cardiovsacular the heart Coenzyme Q and cardiovascular health. People with heart failure commonly experience a relapsing and remitting disease course, with periods of stability and episodes of decompensation failure to cope with heart damageleading to worsening symptoms that necessitate hospitalisation. Treatment options for heart failure range from drugs to heart transplantation, with each having its own limitations. Coenzyme Q10 or ubiquinone has been suggested as a treatment option in some trials. Coenzyme Q10 is a non-prescription nutritional supplement. It is a fat-soluble molecule that has a role in energy production within the cells of the body.
0 thoughts on “Coenzyme Q and cardiovascular health”